Qbic II is happy to announce its participation in the € 28M funding round of EyeD pharma, a Belgian biotech company working to improve the treatment options available to Glaucoma patients. Related press coverage can be found via the following links:
De Tijd: https://www.tijd.be/ondernemen/farma-biotech/28-miljoen-euro-voor-luiks-oogimplantaat/10129226.html